Wong, Yee Hwa
Kumar, Akshita
Liew, Chong Wai
Tharakaraman, Kannan
Srinivasaraghavan, Kannan http://orcid.org/0000-0002-9539-5249
Sasisekharan, Ram
Verma, Chandra
Lescar, Julien
Article History
Received: 4 September 2017
Accepted: 21 May 2018
First Online: 31 May 2018
Competing Interests
: R.S. is a founder, shareholder, and member of the board of Visterra, Inc, which is performing clinical evaluation of mAb 513. The other authors have no competing interests to declare.